Landscape Capital Management, L.L.C. Myriad Genetics Inc Transaction History

Landscape Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$14.51 - $20.99 $2.22 Million - $3.21 Million	152,773 New	152,773 $2.22 Million
Q2 2022 Aug 05, 2022	BUY	$16.45 - $25.88 $942,469 - $1.48 Million	57,293 New	57,293 $1.04 Million
Q4 2020 Feb 09, 2021	SELL	$12.16 - $19.77 $828,339 - $1.35 Million	-68,120 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$11.25 - $14.75 $766,350 - $1 Million	68,120 New	68,120 $888,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.